| 000 | 01595 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515184305.0 | ||
| 264 | 0 | _c20091013 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e3181af0b6e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDobkin, Bruce H | |
| 245 | 0 | 0 |
_aAssessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). _h[electronic resource] |
| 260 |
_bNeurology _cSep 2009 |
||
| 300 |
_a736; author reply 737-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aBotulinum Toxins _xtherapeutic use |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMuscle Spasticity _xdrug therapy |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aOutcome Assessment, Health Care _xmethods |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 650 | 0 | 4 |
_aStroke _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLandau, William M | |
| 700 | 1 | _aSahrmann, Shirley | |
| 700 | 1 | _aThomas Thach, W | |
| 700 | 1 | _aSimpson, D M | |
| 700 | 1 | _aGracies, J-M | |
| 700 | 1 | _aGraham, K | |
| 700 | 1 | _aHallett, M | |
| 700 | 1 | _aMiyasaki, J | |
| 700 | 1 | _aNaumann, M | |
| 700 | 1 | _aRussman, B | |
| 700 | 1 | _aSimpson, L | |
| 700 | 1 | _aSo, Y | |
| 773 | 0 |
_tNeurology _gvol. 73 _gno. 9 _gp. 736; author reply 737-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e3181af0b6e _zAvailable from publisher's website |
| 999 |
_c19121963 _d19121963 |
||